TechFlow, July 8 — According to The Block, Nasdaq-listed medical technology company BioSig Technologies (BSGM) announced on Monday a financing agreement worth up to $1.1 billion with an undisclosed institutional investor, aimed at advancing its initiative to bring commodity markets on-chain. The financing consists of $100 million in senior secured convertible notes and a $1 billion equity credit facility. This funding follows BioSig's recent merger with Bahamian firm Streamex Exchange Corporation, marking the company’s strategic shift toward tokenizing real-world assets. Henry McPhie, CEO of BioSig and co-founder of Streamex, stated that the company’s mission is to bring liquidity, transparency, and accessibility to the $142 trillion commodities market.
Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / [email protected] ICP License: 琼ICP备2022009338号
